Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation-Reference-Cited by-同舟云学术

Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation

Published:2014-03-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Salazar Carlos A¹,del Aguila Daniel¹,Cordova Erika G¹

Affiliation:

1. Universidad Peruana Cayetano Heredia; Department of Medicine; Avenida Honorio Delgado 430 San Martin de Porres Lima Peru

Publisher

Wiley

Subject

Pharmacology (medical)

Reference70 articles.

1. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomised dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists;Lip;European Heart Journal,2009

2. NCT01136408 Open label, randomised exploratory dose response study in pharmacodynamics and safety of BIBR 1048 (110 mg b.i.d. and 150 mg b.i.d.) for 12 weeks in patients with non-valvular atrial fibrillation in comparison to warfarin http://www.clinicaltrials.gov/ct2/show/NCT01136408 accessed 2007 (reported)

3. Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation;Olsson;Thrombosis and Haemostasis,2010

4. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with non valvular atrial fibrillation (PETRO Study);Ezekowitz;American Journal of Cardiology,2007

5. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;New England Journal of Medicine,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries;Stroke and Vascular Neurology;2024-02-08

2. An Inconspicuous Offender: Apixaban-Induced Anticoagulant-Related Nephropathy;Cureus;2023-09-04

3. A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States;American Journal of Cardiovascular Drugs;2023-06-10

4. Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021;International Journal of Environmental Research and Public Health;2023-01-13

5. Dabigatran Versus Warfarin in Atrial Fibrillation (RE-LY)-2009;Top Articles in Primary Care;2023